Thursday, March 6, 2014

Recent Research Study Mayo Clinic Confirms the Worse

The call is for all women to sign petition -I have initiated in Canada but should be known globally due lack of information given to patients that can directly affect their mortality.

SIGN PETITION TO SAVE YOUR LIFE & OTHER WOMEN
COPY & PASTE 
https://www.change.org/en-CA/petitions/canadian-government-to-cover-cyp2d6-blood-test-for-women-on-tamoxifen-for-breast-cancer-mandatory-cyp2d6-blood-test-for-women-on-tamoxifen-to-prevent-further-recurrences?share_id=CnJCxDzHDR&utm_campaign=mailto_link&utm_medium=email&utm_source=share_petition


Here is recent research article by Mayo http://www.medscape.com/viewarticle/776933
recent studies confirming needing this bloodwork otherwise
he new study suggests that CYP2D6 can predict ineffectiveness. The results show that after 5 years of taking tamoxifen, breast cancer patients with genetic alterations of CYP2D6 who are considered to be poor metabolizers of tamoxifen experienced disease recurrence or died at a rate that was 2.5 times higher than women with normal CYP2D6 enzyme activity.

Tuesday, February 4, 2014

Changing Breast Cancer Survival on Tamoxifen


 

The new study shows that women should stay on Tamoxifen for 10 years except that no blood work is done in Canada to determine whether the person can metabolize the Tamoxifen. This directly affects whether the person will have a recurrence. Can 20% of breast cancer survivors take that gamble? A test is available in US for about $60 but not available in Canada.

Little has been done or discussed the effects of this, while the drug company keeps pumping out the drug.

SIGN THIS ON CHANGE.ORG TO SAVE YOUR LIFE OR SOMEONE YOU LOVE
I CANNOT DIRECT LINK- COPY & PASTE IN BROWSER
 http://chn.ge/18LJFBG